- Home
- LUMO vs PIII Comparison
LUMO vs PIII Comparison
Compare LUMO & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUMO
- PIII
- Stock Information
- Founded
- LUMO 2011
- PIII 2015
- Country
- LUMO United States
- PIII United States
- Employees
- LUMO N/A
- PIII N/A
- Industry
- LUMO Biotechnology: Pharmaceutical Preparations
- PIII Medical/Nursing Services
- Sector
- LUMO Health Care
- PIII Health Care
- Exchange
- LUMO Nasdaq
- PIII Nasdaq
- Market Cap
- LUMO 37.4M
- PIII 33.2M
- IPO Year
- LUMO N/A
- PIII N/A
- Fundamental
- Price
- LUMO $4.34
- PIII $0.20
- Analyst Decision
- LUMO Buy
- PIII Buy
- Analyst Count
- LUMO 4
- PIII 3
- Target Price
- LUMO $9.38
- PIII $2.38
- AVG Volume (30 Days)
- LUMO 133.0K
- PIII 429.8K
- Earning Date
- LUMO 11-07-2024
- PIII 11-12-2024
- Dividend Yield
- LUMO N/A
- PIII N/A
- EPS Growth
- LUMO N/A
- PIII N/A
- EPS
- LUMO N/A
- PIII N/A
- Revenue
- LUMO $2,205,000.00
- PIII $1,476,630,000.00
- Revenue This Year
- LUMO $184.11
- PIII $21.45
- Revenue Next Year
- LUMO N/A
- PIII N/A
- P/E Ratio
- LUMO N/A
- PIII N/A
- Revenue Growth
- LUMO 26.94
- PIII 25.38
- 52 Week Low
- LUMO $1.37
- PIII $0.19
- 52 Week High
- LUMO $4.58
- PIII $1.78
- Technical
- Relative Strength Index (RSI)
- LUMO 4.26
- PIII 33.57
- Support Level
- LUMO $4.31
- PIII $0.19
- Resistance Level
- LUMO $4.39
- PIII $0.23
- Average True Range (ATR)
- LUMO 0.03
- PIII 0.02
- MACD
- LUMO -0.44
- PIII 0.00
- Stochastic Oscillator
- LUMO 0.00
- PIII 16.92
About LUMO Lumos Pharma Inc.
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.